| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 4 | +100.00% | +14.15% | +1.31% | +12.84% | +11.50% | — |
| 14d | 4 | +75.00% | +15.81% | +1.21% | +14.60% | +15.64% | — |
| 30d | 4 | +100.00% | +16.82% | +5.05% | +11.76% | +14.39% | — |
| 60d | 4 | +25.00% | -7.41% | +4.52% | -11.03% | -29.75% | — |
| 90d | 4 | +25.00% | -15.61% | +4.96% | -20.58% | -40.17% | — |
| 180d | 4(1 pending) | +33.33% | +3.90% | +11.29% | -7.39% | -67.23% | — |
| 1y | 4(3 pending) | +100.00% | +75.76% | +13.71% | +62.05% | +62.05% | — |
| 2y | 4(3 pending) | +0.00% | -52.16% | +43.66% | -95.82% | -95.82% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| LENZ LENZ THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 7,500 | $8.57 | $64.3K | 12,886 | Mar 27, 2026 | Mar 30, 2026 ↗ | View → |
| LENZ LENZ THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 84,200 | — | — | 84,200 | Jan 2, 2026 | Jan 6, 2026 ↗ | View → |
| LENZ LENZ THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 14,000 | — | — | 14,000 | Jan 2, 2026 | Jan 6, 2026 ↗ | View → |
| LENZ LENZ THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 20 | $22.71 | $454 | 3,208 | Nov 7, 2025 | Nov 7, 2025 ↗ | View → |
| LENZ LENZ THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 2,178 | $22.76 | $49.6K | 5,386 | Nov 7, 2025 | Nov 7, 2025 ↗ | View → |
| LENZ LENZ THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 70,444 | — | — | 70,444 | Jan 9, 2025 | Jan 13, 2025 ↗ | View → |
| LENZ LENZ THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 3,188 | $15.68 | $50.0K | 3,188 | May 14, 2024 | May 15, 2024 ↗ | View → |
| LENZ LENZ THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 200,000 | — | — | 200,000 | Mar 21, 2024 | Mar 25, 2024 ↗ | View → |